Horizon Therapeutics PLC reports results for the quarter ended in June - Earnings Summary

Horizon Therapeutics

08/08/2023 13:24

* Horizon Therapeutics PLC  HZNP.OQ  reported quarterly
adjusted
earnings of $1.20​​ per share for the quarter ended in June. The
mean expectation of six analysts for the quarter was
for earnings of $1.03 per share.
    * Revenue rose 7.8% to $944.96 million from a year ago;
analysts
expected $867.69 million. 
    * Horizon Therapeutics PLC's reported EPS for the quarter
was 54
cents​.
    * The mean earnings estimate of analysts had fallen by
about 12.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Horizon Therapeutics PLC shares had fallen by 1.7% this
quarter and lost 11.1% so far this year.
    * The company reported quarterly net income of $127.07
million.
    * Wall Street's median 12-month price target for Horizon
Therapeutics PLC is $116.50 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 8 at 12:24 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      1.03           1.20           Beat
 Mar. 31 2023      1.12           0.83           Missed
 Dec. 31 2022      1.09           1.21           Beat
 Sep. 30 2022      1.01           1.25           Beat